EMCrit 428 â A Few Things (ARISE Fluids, Bicarb Studies & More)
This episode summarizes several key trials debuting at the Critical Care Reviews 2026 meeting, with a significant focus on the ARISE Fluids trial regarding fluid management in septic shock. The discussion addresses the implications of this data for the long-standing 30 mL/kg fluid resuscitation mandate. Beyond sepsis fluids, the review also covers updated evidence concerning sodium bicarbonate use in both cardiac arrest and metabolic derangements, while also correcting a common misunderstanding about acid-base status during diabetic ketoacidosis resolution. It's a high-yield roundup covering several evolving areas of critical care practice.
This episode summarizes several key trials debuting at the Critical Care Reviews 2026 meeting, with a significant focus on the ARISE Fluids trial regarding fluid management in septic shock. The discussion addresses the implications of this data for the long-standing 30 mL/kg fluid resuscitation mandate. Beyond sepsis fluids, the review also covers updated evidence concerning sodium bicarbonate use in both cardiac arrest and metabolic derangements, while also correcting a common misunderstanding about acid-base status during diabetic ketoacidosis resolution. It's a high-yield roundup covering several evolving areas of critical care practice.
Show moreShow less
The ARISE Fluids trial suggests that continuing aggressive fluid resuscitation in septic shock patients who have already received substantial initial volumes may not be beneficial, especially when considering vasopressor use. Remember that the eligibility criteria for this data included prior large-volume fluid administration, so interpret these findings cautiously at the bedside. Also, keep the misconceptions about bicarbonate use and DKA resolution top of mind.